YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Novartis bets $9.7B on cholesterol drug

Posted online

Novartis AG penned a $9.7 billion purchase deal for Medicines Co.

Bloomberg reports the acquisition focuses mostly on a single treatment: experimental cholesterol drug inclisiran.

Similarly, last year Novartis gained muscle disease gene therapy Zolgensma by buying drugmaker AveXis Inc. for $8.7 billion.

Read more from Bloomberg.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
From the Ground Up: Springfield-Greene County Library District Republic Branch

Under construction beside the existing Republic branch of the Springfield-Greene County Library District – which remains in operation throughout the project – is a new building that will double the size of the original, according to library officials.

Most Read
Update cookies preferences